Paolo Strati, MD; University of Texas MD Anderson Cancer Center 5Live #ASCO20
5:45
Key insights on Prognostic impact of dose, duration, and timing of corticosteroid therapy in patients with large B-cell lymphoma treated with standard of care axicabtagene ciloleucel (Axi-cel).
Key insights on Prognostic impact of dose, duration, and timing of corticosteroid therapy in patients with large B-cell lymphoma treated with standard of care axicabtagene ciloleucel (Axi-cel).
Diffuse Large B Cell Lymphoma Similar Videos
-
Module 3_Emerging Approaches for Frontline Treatment_Gilles Salles, MD, PhD_Christopher Flowers, MD, MS_Laurie Sehn, MD, MPH
23:39
-
Prevention of CNS Progression in Diffuse Large B-cell Lymphoma_Craig Portell, MD; #IUCLS22
19:43
-
Podium to Practice: Updates in the Treatment of DLBCL – From Chemotherapy to Novel Targeted Therapies_Justin Kline, MD_Laurie Sehn, MD
30:48